Ironwood Pharmaceuticals (IRWD) Return on Sales (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (down 1.0% YoY), and the FY2025 full-year result was 0.0%, down 1.0% from the prior year.
• Return on Sales grew to 0.0% in Q1 2026, from 0.03% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.02% in Q4 2024 to a low of 0.1% in Q2 2023.
• A 5-year average of 0.01% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales slipped 11 bps in 2023 and climbed 10 bps in 2024, its largest moves.
• Tracing IRWD's Return on Sales over 5 years: stood at 0.01% in 2022, then plunged by 205 bps to 0.01% in 2023, then jumped by 238 bps to 0.02% in 2024, then slumped by 300 bps to 0.03% in 2025, then jumped by 111 bps to 0.0% in 2026.
• Business Quant data shows IRWD's Return on Sales at 0.0% in Q1 2026, 0.03% in Q4 2025, and 0.0% in Q3 2025.